Sorbistin A
1 (
1b) and sorbistin B (
1a), bioactive components of a new type of aminoglycoside antibiotic produced by a strain of
Pseudomonas species, have been converted into a key intermediate
3 by blocking of the 1- and 4-amino groups of sorbistins with dimedone and subsequent deacylation of the 4'-N-acyl group. Some 4'-N-acyl analogs of sorbistin (
1e-1t) have been synthesized by 4'-N-acylation of
3 with an appropriate reactive derivative of carboxylic acids (mixed anhydride, acid chloride or activated ester) followed by deblocking of the protected group with bromine or sodium nitrite. Chemical interconversion of three natural sorbistins A
1 (
1b), A
2 (
1c) and B (
1a) has been performed by this procedure. The 1-N-acyl (
4a-4c) and the 1, 4'-N, N-diacyl analogs (
6a-6c) have been prepared by direct N-acylation of sorbistin D (
1d) (the 4'-desacyl derivative) and sorbistin A
1, respectively. On the other hand, the 4-N-acyl (
5a and
5b) and the 4, 4'-N, N-diacyl derivatives (
7a and
7b) have been prepared by acylation and subsequent hydrogenolysis of 1-N-Cbz-sorbistin D (
4b) and 1-N-Cbz-sorbistin A, (
6b), respectively.
Determination of
in vitro antimicrobial activity showed that the 4'-N-propionyl (
1b) and the 4'-N-cyclopropylcarbonyl (
1s) derivatives are the most active members of the 4'-N-acyl derivatives. Elongation and shortening of the side chain and introduction of functional groups
decreased the activity. N-Acylation of the amino group at C-1 or at C-4 gave virtually inactive products.
View full abstract